Journal of Clinical Endocrinology & Metabolism, Vol 77, 151-156, Copyright © 1993 by Endocrine Society

ARTICLES

The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone

M Reincke, B Allolio, G Wurth and W Winkelmann
Department of Medicine, University of Wurzburg, Germany.

Plasma ACTH and cortisol concentrations are frequently elevated in patients in intensive care units (ICU). To examine the functional integrity of the hypothalamic-pituitary-adrenal axis during critical illness, we evaluated prospectively 53 ICU patients in a general medical ICU. Thirty-one patients and 7 normal controls underwent an overnight dexamethasone suppression test (3 mg dexamethasone, orally, at 2300 h). Plasma ACTH and serum cortisol were measured at 0900 h. In a separate experiment, 22 patients and 7 control subjects underwent a CRH stimulation test [100 micrograms human (h) CRH, iv]. ACTH and cortisol concentrations were determined from -15 to 120 min. Compared to normal controls, plasma ACTH and serum cortisol concentrations were not fully suppressible by dexamethasone [mean +/- SEM: plasma ACTH, 21 +/- 4 vs. 3 +/- 0.5 pg/mL (4.7 +/- 0.9 vs. 0.7 +/- 0.1 pmol/L); serum cortisol, 13.9 +/- 1.9 vs. 1.5 +/- 0.3 micrograms/dL (390 +/- 50 vs. 40 +/- 10 nmol/L); P = 0.0001], demonstrating an altered glucocorticoid feedback in the ICU patients. Patients undergoing hCRH stimulation had clearly elevated mean baseline plasma ACTH and serum cortisol concentrations [ACTH, 78 +/- 20 pg/mL vs. 15 +/- 3 in controls (17.2 +/- 4.4 vs. 3.4 +/- 0.7 pmol/L; P = 0.007); cortisol, 36.8 +/- 3.4 micrograms/dL vs. 9.6 +/- 1.2 (1020 +/- 80 vs. 260 +/- 30 nmol/L; P = 0.0001)]. Despite elevated baseline glucocorticoid concentrations, stimulation with hCRH resulted in significantly higher peak plasma ACTH concentrations 15 min after hCRH than in controls [134 +/- 31 vs. 48 +/- 9 pg/mL (29.5 +/- 6.8 vs. 10.6 +/- 2.0 pmol/L); P < 0.05]. Serum cortisol concentrations in ICU patients were significantly elevated throughout the test period (P = 0.0001) and rose to a peak of 43.9 +/- 3.5 micrograms/dL compared to 18.2 +/- 2.0 micrograms/dL in controls (1210 +/- 70 vs. 500 +/- 60 nmol/L). We conclude that ICU patients have a markedly altered responsiveness of their pituitary corticotroph to suppression with dexamethasone and stimulation with hCRH. These findings may be explained by altered pituitary glucocorticoid feedback and/or hypersecretion of peptides with CRH-like activity (vasopressin and cytokines) during critical illness.

This article has been cited by other articles:

				I. Wallace, S. Cunningham, and J. Lindsay The diagnosis and investigation of adrenal insufficiency in adults Ann Clin Biochem, September 1, 2009; 46(5): 351 - 367. [Abstract] [Full Text] [PDF]

				N. Tran, A. Koch, R. Berkels, O. Boehm, P. A. Zacharowski, G. Baumgarten, P. Knuefermann, M. Schott, W. Kanczkowski, S. R. Bornstein, et al. Toll-Like Receptor 9 Expression in Murine and Human Adrenal Glands and Possible Implications during Inflammation J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2773 - 2783. [Abstract] [Full Text] [PDF]

				B. M. Arafah Hypothalamic Pituitary Adrenal Function during Critical Illness: Limitations of Current Assessment Methods J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3725 - 3745. [Abstract] [Full Text] [PDF]

				R. I. Dorin, C. R. Qualls, and L. M. Crapo Diagnosis of Adrenal Insufficiency Ann Intern Med, August 5, 2003; 139(3): 194 - 204. [Abstract] [Full Text] [PDF]

				G.U. Meduri, P. Carratu, and A.X. Freire Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS Eur. Respir. J., August 1, 2003; 22(42_suppl): 57s - 64s. [Abstract] [Full Text] [PDF]

				A. Beishuizen and L. G. Thijs Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis Innate Immunity, February 1, 2003; 9(1): 3 - 24. [Abstract] [PDF]

				P. E. Marik and G. P. Zaloga Adrenal Insufficiency in the Critically Ill: A New Look at an Old Problem Chest, November 1, 2002; 122(5): 1784 - 1796. [Abstract] [Full Text] [PDF]

				G. U. Meduri, E. A. Tolley, G. P. Chrousos, and F. Stentz Prolonged Methylprednisolone Treatment Suppresses Systemic Inflammation in Patients with Unresolving Acute Respiratory Distress Syndrome . Evidence for Inadequate Endogenous Glucocorticoid Secretion and Inflammation-induced Immune Cell Resistance to Glucocorticoids Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 983 - 991. [Abstract] [Full Text] [PDF]

				J. Krakoff, C. A. Koch, K. A. Calis, R. H. Alexander, and L. K. Nieman Use of a Parenteral Propylene Glycol-Containing Etomidate Preparation for the Long-Term Management of Ectopic Cushing's Syndrome J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4104 - 4108. [Abstract] [Full Text] [PDF]

				E. P. Rivers, M. Gaspari, G. A. Saad, M. Mlynarek, J. Fath, H. M. Horst, and J. Wortsman Adrenal Insufficiency in High-Risk Surgical ICU Patients Chest, March 1, 2001; 119(3): 889 - 896. [Abstract] [Full Text] [PDF]

				R. M. Sapolsky, S. C. Alberts, and J. Altmann Hypercortisolism Associated With Social Subordinance or Social Isolation Among Wild Baboons Arch Gen Psychiatry, December 1, 1997; 54(12): 1137 - 1143. [Abstract] [PDF]

				S. W.J. Lamberts, H. A. Bruining, and F. H. de Jong Corticosteroid Therapy in Severe Illness N. Engl. J. Med., October 30, 1997; 337(18): 1285 - 1292. [Full Text] [PDF]

				T. M. E. Davis, L. T. A. Thu, T. Q. Binh, K. Robertson, J. R. Dyer, P. T. Danh, D. Meyer, M. H. Beaman, and T. K. Anh The Hypothalamic-Pituitary-Adrenocortical Axis in Severe Falciparum Malaria: Effects of Cytokines J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3029 - 3033. [Abstract] [Full Text] [PDF]